Envafolimab+Lenvatinib

DRUG2 trials

Sponsors

3D Medicines (Sichuan) Co., Ltd., Fudan University

Conditions

Advanced Endometrial CancerClear Cell Renal Cell Cancer (ccRCC)Liver Metastasis

Phase 2

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

RecruitingNCT05112991

3D Medicines (Sichuan) Co., Ltd.Advanced Endometrial Cancer

Start: 2022-03-04End: 2026-12-01Target: 108Updated: 2026-03-25

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

Not yet recruitingNCT07256223

Fudan UniversityClear Cell Renal Cell Cancer (ccRCC), Liver Metastasis

Start: 2026-12-01End: 2028-05-30Target: 30Updated: 2026-09-09

Related Papers

Efficacy and safety of combination therapy with envafolimab and lenvatinib in patients with endometrial cancer after failure of first-line platinum-based therapy.

Journal of Clinical Oncology2024-06-01